Filing Details

Accession Number:
0001179110-16-026210
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-06-08 15:55:37
Reporting Period:
2016-06-01
Filing Date:
2016-06-08
Accepted Time:
2016-06-08 15:55:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1235010 Momenta Pharmaceuticals Inc MNTA Biological Products, (No Disgnostic Substances) (2836) 043561634
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1294682 M Bennett Shapiro C/O Momenta Pharmaceuticals, Inc.
675 West Kendall Street
Cambridge MA 02142
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-06-01 5,200 $12.90 5,200 No 4 M Direct
Common Stock Disposition 2016-06-01 5,200 $13.00 10,834 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2016-06-01 5,200 $12.90 5,200 $12.90
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
14,000 2016-06-15 No 4 M Direct
Footnotes
  1. This sale was effected pursuant to a Rule 10B5-1 trading plan adopted by the reporting person on August 6, 2015.
  2. The option, representing a right to purchase a total of 19,200 shares was granted on June 15, 2006 and became exercisable in four equal installments, with the first installment vesting on the three-month anniversary of the grant date and each additional installment vesting at the end of each successive three-month period thereafter.